John S Yi

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Extracorporeal Membrane Oxygenation

Neoadjuvant Chemotherapy

Top Venues

Future oncology (London, England)

Nature communications

Breast cancer research and treatment

University of Alabama at Birmingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Alabama at Birmingham Aug 20 2006 - Dec 10 2010

United States

PHD :: Microbiology

Wake Forest University Aug 20 2002 - May 20 2006

United States

BSC

Publications

Antoinette R Tan, Joyce O'Shaughnessy, Subing Cao, Sarah Ahn, John S Yi
Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer. Breast cancer research and treatment (2023)
Shom Goel, Antoinette R Tan, Hope S Rugo, Philippe Aftimos, Zoran Andrić, Andrew P Beelen, Jingshan Zhang, John S Yi, Rajesh K Malik, Joyce O'Shaughnessy
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2. Future oncology (London, England) (2022)
Robin Schmitz, Zachary W Fitch, Paul M Schroder, Ashley Y Choi, Miriam Manook, Janghoon Yoon, Mingqing Song, John S Yi, Sanjay Khandelwal, Gowthami M Arepally, Alton Brad Farris, Edimara S Reis, John D Lambris, Jean Kwun, Stuart J Knechtle
C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates. Nature communications 12 (1) (2021)
John S Yi, Marilyn Rosa-Bray, Janet Staats, Pearl Zakroysky, Cliburn Chan, Melissa A Russo, Chelsae Dumbauld, Scott White, Todd Gierman, Kent J Weinhold, Jeffrey T Guptill
Establishment of normative ranges of the healthy human immune system with comprehensive polychromatic flow cytometry profiling. PloS one 14 (12) (2019)